DA
KLRS

Denali Advisors’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Denali Advisors’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-283
Closed -$22.1K – 552
2023
Q2 		$22.1K Hold
283
– – 0.01% 334
2023
Q1 		$25.6K Hold
283
– – 0.01% 277
2022
Q4 		$33.3K Hold
283
– – 0.01% 267
2022
Q3 		$51K Buy
+283
New +$51K 0.02% 208